Buchumschlag

Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients: guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)

Fever may be the only clinical symptom at the onset of infection in neutropenic cancer patients undergoing myelosuppressive chemotherapy. A prompt and evidence-based diagnostic and therapeutic approach is mandatory. A systematic search of current literature was conducted, including only full papers...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Heinz, W. J. (VerfasserIn) , Buchheidt, Dieter (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2017
In: Annals of hematology
Year: 2017, Jahrgang: 96, Heft: 11, Pages: 1775-1792
ISSN:1432-0584
DOI:10.1007/s00277-017-3098-3
Online-Zugang:Verlag, Volltext: http://dx.doi.org/10.1007/s00277-017-3098-3
Verlag, Volltext: http://link.springer.com/article/10.1007/s00277-017-3098-3
Volltext
Verfasserangaben:W.J. Heinz, D. Buchheidt, M. Christopeit, M. von Lilienfeld-Toal, O.A. Cornely, H. Einsele, M. Karthaus, H. Link, R. Mahlberg, S. Neumann, H. Ostermann, O. Penack, M. Ruhnke, M. Sandherr, X. Schiel, J.J. Vehreschild, F. Weissinger, G. Maschmeyer

MARC

LEADER 00000caa a2200000 c 4500
001 1576736741
003 DE-627
005 20220814171639.0
007 cr uuu---uuuuu
008 180621s2017 xx |||||o 00| ||eng c
024 7 |a 10.1007/s00277-017-3098-3  |2 doi 
035 |a (DE-627)1576736741 
035 |a (DE-576)506736741 
035 |a (DE-599)BSZ506736741 
035 |a (OCoLC)1341012055 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Heinz, W. J.  |e VerfasserIn  |0 (DE-588)1161564004  |0 (DE-627)1024849708  |0 (DE-576)506737012  |4 aut 
245 1 0 |a Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients  |b guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)  |c W.J. Heinz, D. Buchheidt, M. Christopeit, M. von Lilienfeld-Toal, O.A. Cornely, H. Einsele, M. Karthaus, H. Link, R. Mahlberg, S. Neumann, H. Ostermann, O. Penack, M. Ruhnke, M. Sandherr, X. Schiel, J.J. Vehreschild, F. Weissinger, G. Maschmeyer 
264 1 |c 2017 
300 |a 18 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Published online: 30 August 2017 
500 |a Gesehen am 21.06.2018 
520 |a Fever may be the only clinical symptom at the onset of infection in neutropenic cancer patients undergoing myelosuppressive chemotherapy. A prompt and evidence-based diagnostic and therapeutic approach is mandatory. A systematic search of current literature was conducted, including only full papers and excluding allogeneic hematopoietic stem cell transplant recipients. Recommendations for diagnosis and therapy were developed by an expert panel and approved after plenary discussion by the AGIHO. Randomized clinical trials were mainly available for therapeutic decisions, and new diagnostic procedures have been introduced into clinical practice in the past decade. Stratification into a high-risk versus low-risk patient population is recommended. In high-risk patients, initial empirical antimicrobial therapy should be active against pathogens most commonly involved in microbiologically documented and most threatening infections, including Pseudomonas aeruginosa, but excluding coagulase-negative staphylococci. In patients whose expected duration of neutropenia is more than 7 days and who do not respond to first-line antibacterial treatment, specifically in the absence of mold-active antifungal prophylaxis, further therapy should be directed also against fungi, in particular Aspergillus species. With regard to antimicrobial stewardship, treatment duration after defervescence in persistently neutropenic patients must be critically reconsidered and the choice of anti-infective agents adjusted to local epidemiology. This guideline updates recommendations for diagnosis and empirical therapy of fever of unknown origin in adult neutropenic cancer patients in light of the challenges of antimicrobial stewardship. 
700 1 |a Buchheidt, Dieter  |d 1955-  |e VerfasserIn  |0 (DE-588)1028287461  |0 (DE-627)730538621  |0 (DE-576)375787380  |4 aut 
773 0 8 |i Enthalten in  |t Annals of hematology  |d Berlin : Springer, 1991  |g 96(2017), 11, Seite 1775-1792  |h Online-Ressource  |w (DE-627)253389852  |w (DE-600)1458429-3  |w (DE-576)072283157  |x 1432-0584  |7 nnas  |a Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO) 
773 1 8 |g volume:96  |g year:2017  |g number:11  |g pages:1775-1792  |g extent:18  |a Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO) 
856 4 0 |u http://dx.doi.org/10.1007/s00277-017-3098-3  |x Verlag  |x Resolving-System  |3 Volltext 
856 4 0 |u http://link.springer.com/article/10.1007/s00277-017-3098-3  |x Verlag  |3 Volltext 
951 |a AR 
992 |a 20180621 
993 |a Article 
994 |a 2017 
998 |g 1028287461  |a Buchheidt, Dieter  |m 1028287461:Buchheidt, Dieter  |d 60000  |d 61200  |e 60000PB1028287461  |e 61200PB1028287461  |k 0/60000/  |k 1/60000/61200/  |p 2 
999 |a KXP-PPN1576736741  |e 3013331828 
BIB |a Y 
SER |a journal 
JSO |a {"note":["Published online: 30 August 2017","Gesehen am 21.06.2018"],"type":{"media":"Online-Ressource","bibl":"article-journal"},"recId":"1576736741","language":["eng"],"person":[{"given":"W. J.","family":"Heinz","role":"aut","display":"Heinz, W. J.","roleDisplay":"VerfasserIn"},{"given":"Dieter","family":"Buchheidt","role":"aut","display":"Buchheidt, Dieter","roleDisplay":"VerfasserIn"}],"title":[{"title_sort":"Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients","subtitle":"guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)","title":"Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients"}],"physDesc":[{"extent":"18 S."}],"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Berlin ; Heidelberg ; New York","dateIssuedDisp":"1991-","dateIssuedKey":"1991","publisher":"Springer"}],"id":{"issn":["1432-0584"],"eki":["253389852"],"zdb":["1458429-3"]},"type":{"bibl":"periodical","media":"Online-Ressource"},"disp":"Diagnosis and empirical treatment of fever of unknown origin (FUO) in adult neutropenic patients guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Medical Oncology (DGHO)Annals of hematology","note":["Gesehen am 24.04.2025","Fortsetzung der Druck-Ausgabe","Ungezählte Beil. ab 80.2001: Supplement"],"language":["eng"],"recId":"253389852","pubHistory":["62, 1 (Februrary 1991)-"],"part":{"year":"2017","issue":"11","pages":"1775-1792","volume":"96","text":"96(2017), 11, Seite 1775-1792","extent":"18"},"titleAlt":[{"title":"Hematology"}],"title":[{"title_sort":"Annals of hematology","title":"Annals of hematology","subtitle":"organ of: Gesellschaft für Thrombose- und Hämostaseforschung, DGHO, Deutsche Gesellschaft für Hämatologie und Onkologie e.V., ÖGHO, Österreichische Gesellschaft für Hämatologie und Onkologie"}]}],"name":{"displayForm":["W.J. Heinz, D. Buchheidt, M. Christopeit, M. von Lilienfeld-Toal, O.A. Cornely, H. Einsele, M. Karthaus, H. Link, R. Mahlberg, S. Neumann, H. Ostermann, O. Penack, M. Ruhnke, M. Sandherr, X. Schiel, J.J. Vehreschild, F. Weissinger, G. Maschmeyer"]},"origin":[{"dateIssuedDisp":"2017","dateIssuedKey":"2017"}],"id":{"doi":["10.1007/s00277-017-3098-3"],"eki":["1576736741"]}} 
SRT |a HEINZWJBUCDIAGNOSISA2017 

Ähnliche Einträge